Australia
Argentina 
Austria 
Brazil 
Canada 
Germany 
Ireland 
Italy 
Malaysia 
Mexico 
New Zealand 
Poland 
South Africa 
United Kingdom 
United States Atrial fibrillation
A new study has revealed a higher mortality risk in COVID-19 patients who are newly diagnosed with atrial fibrillation. The incidence and prognosis of newly diagnosed AF in patients hospitalized due to SARS-CoV-2 have been a cause for concern. This finding highlights the importance of monitoring and managing atrial fibrillation in COVID-19 patients to improve outcomes.
Impact of atrial fibrillation on COVID-19 patients
The presence of atrial fibrillation in COVID-19 patients has been linked to a higher risk of mortality. Healthcare providers should be vigilant in identifying and treating atrial fibrillation in COVID-19 patients to reduce the risk of adverse outcomes. This new study sheds light on the need for further research and interventions to address the impact of atrial fibrillation on COVID-19 patients.
